Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: A systematic review and meta-analysis of randomized controlled trials

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Inhibitor Treatment

The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.06.009 ◽

2019 ◽

Vol 154 ◽

pp. 101-115 ◽

Cited By ~ 5

Author(s):

Maria Ida Maiorino ◽

Paolo Chiodini ◽

Giuseppe Bellastella ◽

Lorenzo Scappaticcio ◽

Miriam Longo ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes: a systematic review and meta-analysis of 21 randomized controlled trials

Endocrine ◽

10.1007/s12020-020-02193-9 ◽

2020 ◽

Vol 68 (3) ◽

pp. 508-517 ◽

Cited By ~ 2

Author(s):

Suhui Qie ◽

Xuejing Li ◽

Xianying Wang ◽

Yang Liu ◽

Jingxin Li ◽

...

Keyword(s):

Systematic Review ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Long Acting

Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Diabetes Obesity and Metabolism ◽

10.1111/dom.12541 ◽

2015 ◽

Vol 17 (11) ◽

pp. 1065-1074 ◽

Cited By ~ 31

Author(s):

T. Karagiannis ◽

A. Liakos ◽

E. Bekiari ◽

E. Athanasiadou ◽

P. Paschos ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Diabetes Care ◽

10.2337/dc16-1957 ◽

2017 ◽

Vol 40 (4) ◽

pp. 614-624 ◽

Cited By ~ 52

Author(s):

Maria Ida Maiorino ◽

Paolo Chiodini ◽

Giuseppe Bellastella ◽

Annalisa Capuano ◽

Katherine Esposito ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials

Acta Diabetologica ◽

10.1007/s00592-017-1054-2 ◽

2017 ◽

Vol 54 (12) ◽

pp. 1101-1114 ◽

Cited By ~ 15

Author(s):

Matteo Monami ◽

Ilaria Dicembrini ◽

Besmir Nreu ◽

Francesco Andreozzi ◽

Giorgio Sesti ◽

...

Keyword(s):

Systematic Review ◽

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Predictors Of Response ◽

Glucagon Like Peptide ◽

Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials胰高血糖素样肽-1类似物对非糖尿病肥胖/超重成人的减重作用：一篇对随机对照试验进行的系统评价及meta分析

Journal of Diabetes ◽

10.1111/1753-0407.12198 ◽

2014 ◽

Vol 7 (3) ◽

pp. 329-339 ◽

Cited By ~ 22

Author(s):

Fang Zhang ◽

Yuzhen Tong ◽

Na Su ◽

Yi Li ◽

Lizhi Tang ◽

...

Keyword(s):

Systematic Review ◽

Weight Loss ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Overweight Adults ◽

Loss Effect

Glucagon-like peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-analysis of randomized controlled trials

Scientific Reports ◽

10.1038/s41598-017-16018-9 ◽

2017 ◽

Vol 7 (1) ◽

Cited By ~ 4

Author(s):

Fang Zhang ◽

Lizhi Tang ◽

Yuwei Zhang ◽

Qingguo Lü ◽

Nanwei Tong

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Diabetes Patients

Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta‐analysis of randomized controlled trials

British Journal of Clinical Pharmacology ◽

10.1111/bcp.15041 ◽

2021 ◽

Author(s):

Ibadete Bytyçi ◽

Gani Bajraktari ◽

Peter E. Penson ◽

Michael Y. Henein ◽

Maciej Banach ◽

...

Keyword(s):

Systematic Review ◽

Coronary Artery Disease ◽

Coronary Artery ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Artery Disease

A commentary on “The efficacy and safety of probiotics for patients with constipation predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials” [Int. J. Surg. 2020; 79: 111–119]

International Journal of Surgery ◽

10.1016/j.ijsu.2021.105993 ◽

2021 ◽

pp. 105993

Author(s):

Guanhua Rao ◽

Zhijian Meng

Keyword(s):

Systematic Review ◽

Irritable Bowel Syndrome ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Irritable Bowel

Impact of glucagon‐like peptide‐1 receptor agonists on adiponectin concentrations: a meta‐analysis of randomized controlled trials

British Journal of Clinical Pharmacology ◽

10.1111/bcp.14855 ◽

2021 ◽

Author(s):

Luis E. Simental‐Mendía ◽

Adriana Sánchez‐García ◽

Enrique Linden‐Torres ◽

Mario Simental‐Mendía

Keyword(s):

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽